201. An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis.
- Author
-
Au KM, Wilson JE, Ting JP, and Wang AZ
- Subjects
- Animals, Mice, Mice, Inbred C57BL, Disease Models, Animal, Female, Injections, Subcutaneous, Extracellular Matrix metabolism, Macrophages immunology, Macrophages drug effects, B7-H1 Antigen metabolism, B7-H1 Antigen immunology, Nanofibers chemistry, Colitis, Ulcerative immunology, Colitis, Ulcerative drug therapy, Colon immunology, Colon pathology
- Abstract
As a chronic autoinflammatory condition, ulcerative colitis is often managed via systemic immunosuppressants. Here we show, in three mouse models of established ulcerative colitis, that a subcutaneously injected colon-specific immunosuppressive niche consisting of colon epithelial cells, decellularized colon extracellular matrix and nanofibres functionalized with programmed death-ligand 1, CD86, a peptide mimic of transforming growth factor-beta 1, and the immunosuppressive small-molecule leflunomide, induced intestinal immunotolerance and reduced inflammation in the animals' lower gastrointestinal tract. The bioengineered colon-specific niche triggered autoreactive T cell anergy and polarized pro-inflammatory macrophages via multiple immunosuppressive pathways, and prevented the infiltration of immune cells into the colon's lamina propria, promoting the recovery of epithelial damage. The bioengineered niche also prevented colitis-associated colorectal cancer and eliminated immune-related colitis triggered by kinase inhibitors and immune checkpoint blockade., (© 2023. The Author(s), under exclusive licence to Springer Nature Limited.)
- Published
- 2024
- Full Text
- View/download PDF